37891793|t|The Neuroimmune Regulation and Potential Therapeutic Strategies of Optic Pathway Glioma.
37891793|a|Optic pathway glioma (OPG) is one of the causes of pediatric visual impairment. Unfortunately, there is as yet no cure for such a disease. Understanding the underlying mechanisms and the potential therapeutic strategies may help to delay the progression of OPG and rescue the visual morbidities. Here, we provide an overview of preclinical OPG studies and the regulatory pathways controlling OPG pathophysiology. We next discuss the role of microenvironmental cells (neurons, T cells, and tumor-associated microglia and macrophages) in OPG development. Last, we provide insight into potential therapeutic strategies for treating OPG and promoting axon regeneration.
37891793	67	87	Optic Pathway Glioma	Disease	MESH:D020339
37891793	89	109	Optic pathway glioma	Disease	MESH:D020339
37891793	111	114	OPG	Disease	MESH:D020339
37891793	150	167	visual impairment	Disease	MESH:D014786
37891793	346	349	OPG	Disease	MESH:D020339
37891793	365	383	visual morbidities	Disease	MESH:D014786
37891793	429	432	OPG	Disease	MESH:D020339
37891793	481	484	OPG	Disease	MESH:D020339
37891793	578	583	tumor	Disease	MESH:D009369
37891793	625	628	OPG	Disease	MESH:D020339
37891793	718	721	OPG	Disease	MESH:D020339

